Skip to main content
TipRanks
Go Ultimate75% OFF

Nucleus Software Exports Limited (NUCLEUS) AI Stock Analysis

2 Followers
IN:NUCLEUS

Nucleus Software Exports Limited

(NSE:NUCLEUS)

Select Model
Rating:65Neutral
Price Target:INR 669.00â–²(7.56% Upside)
Action:reiterated
Date:09/12/26

Moderate financial performance is the largest factor, supported by a strong balance sheet yet limited by volatile growth and cash flows. Bearish technical signals from price action below moving averages and negative MACD further constrain the score, while reasonable valuation offers partial offset.

Positive Factors
Very Conservative Balance SheetNear-zero debt-to-equity and a growing equity base give Nucleus substantial financial flexibility. This reduces balance-sheet strain, supports continued investment in its financial-services software products, and improves resilience if customer spending or implementation activity softens.
Negative Factors
Revenue Growth DecelerationThe shift from strong earlier expansion to low single-digit revenue growth signals slower business momentum. If sustained, weaker top-line growth could limit operating leverage, reduce the pace of market-share gains, and make future earnings increasingly dependent on cost control.

Nucleus Software Exports Limited (NUCLEUS) vs. iShares MSCI India ETF (INDA)

-35%-30%-25%-20%-15%-10%-5%0%5%IN:NUCLEUS-33.64%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 16.72B
Dividend Yield
2.01%
Average Volume (3M)
1,093
Price to Earnings (P/E)
16.7
Beta (1Y)
1.02
Revenue Growth
1.97%
EPS Growth
-37.75%
Country
India
Employees
1,954
Sector
General
Sector Strength
55
Industry
Software - Application

Nucleus Software Exports Limited Business Overview & Revenue Model

Company Description

Nucleus Software Exports Limited, established in Noida, India, in 1986, is a prominent provider of essential software solutions for the financial services industry. The company delivers crucial lending and transaction banking products to clients span...

Nucleus Software Exports Limited Financial Statement Overview

Summary

Balance sheet strength with low debt and growing equity supports stability, while income statement and cash flow show volatility and slowing revenue growth posing risks.

Income Statement

65Positive

Balance Sheet

85Very Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue8.83B8.76B8.32B8.26B6.34B4.97B
Gross Profit2.15B2.09B2.98B3.31B1.88B765.00M
EBITDA1.44B1.29B1.68B2.71B1.90B716.70M
Net Income1.00B1.17B1.63B1.92B1.28B409.10M
Balance Sheet
Total Assets13.45B12.66B11.53B11.14B8.74B7.37B
Cash, Cash Equivalents and Short-Term Investments4.06B4.14B3.60B4.01B2.77B3.41B
Total Debt71.80M85.50M20.00M45.90M62.60M23.30M
Total Liabilities4.22B3.59B3.39B3.37B2.64B2.43B
Stockholders Equity9.23B9.07B8.14B7.77B6.11B4.94B
Cash Flow
Free Cash Flow0915.70M1.36B1.93B461.40M334.30M
Operating Cash Flow01.20B1.51B2.22B498.40M576.70M
Investing Cash Flow0-551.10M-207.80M-1.97B-127.00M1.59B
Financing Cash Flow0-365.00M-1.26B-301.60M-226.50M-2.13B

Nucleus Software Exports Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price621.95

Price Trends

50DMA666.56Negative
100DMA699.84Negative
200DMA745.70Negative

Market Momentum

MACD-11.25Positive
RSI37.90Neutral
STOCH36.24Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NUCLEUS, the sentiment is Negative. The current price of 621.95 is below the 20-day moving average (MA) of 645.05, below the 50-day MA of 666.56, and below the 200-day MA of 745.70, indicating a bearish trend. The MACD of -11.25 indicates Positive momentum. The RSI at 37.90 is Neutral, neither overbought nor oversold. The STOCH value of 36.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NUCLEUS.

Nucleus Software Exports Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:NUCLEUS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:NEWGENIN:NEWGEN82OutperformINR 62.57B19.43―1.37%6.49%-3.73%
IN:KFINTECHIN:KFINTECH75OutperformINR 165.07B47.10―1.26%26.83%0.50%
IN:EMUDHRAIN:EMUDHRA65NeutralINR 29.42B23.74―0.35%29.74%25.01%
IN:NUCLEUSIN:NUCLEUS65NeutralINR 16.37B16.65―2.01%1.97%-37.75%
IN:INTELLECTIN:INTELLECT60NeutralINR 73.86B20.66―0.76%16.99%-12.47%
IN:RAMCOSYSIN:RAMCOSYS57NeutralINR 20.79B71.00――10.73%236.66%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%IN:NUCLEUSIN:EMUDHRAIN:INTELLECTIN:KFINTECHIN:NEWGENIN:RAMCOSYSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:NUCLEUS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:NUCLEUSNucleus Software Exports Limited621.95-325.17-34.33%
IN:EMUDHRAeMudhra Limited355.30-251.14-41.41%
IN:INTELLECTIntellect Design Arena Ltd525.55-560.68-51.62%
IN:KFINTECHKfin Technologies Limited954.85-119.21-11.10%
IN:NEWGENNewgen Software Technologies Limited439.05-474.96-51.96%
IN:RAMCOSYSRamco Systems Limited552.20-79.35-12.56%

Nucleus Software Exports Limited Corporate Events

Shinhan Finance Selects Nucleus Software’s FinnOne Neo 9.0 in Vietnam

Nov 4, 2026

Nucleus Software provides financial technology platforms for lending and transaction banking, serving financial institutions across Southeast Asia with a particularly established presence in Vietnam. Its FinnOne Neo platform supports loan origination...

Nucleus Software Publishes Financial Results Advertisement for September Quarter

Nov 1, 2026

Nucleus Software Exports Limited is an Indian technology company operating in the software and IT services industry, with a registered office in New Delhi. The company is listed on both the National Stock Exchange of India and BSE, reflecting its pre...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 12, 2026